mental illness

The Value of Board-Certified Psychiatric PharmacistsBeing recognized as a BCPP brings professional recognition and credibility as an expert in psychopharmacology and behavioral health matters.
Genoa MMS: Medication Management for its Community PharmaciesTwo groups are joining forces to enhance medication management.
Pretreatment assessments for females seeking aesthetic treatment
Pretreatment assessments for females seeking aesthetic treatmentIn September, our table of the month focuses on questions you should ask female patients before aesthetic procedures and also which red flags to look for to make sure you know when not treat.
ACA reform must preserve mental health pharmacy accessACA repeal or replacement must focus on how to preserve mental health services and pharmacy access.
Mental health services in primary careIntegrating mental health services within the primary care setting would help to provide continuity of care and benefit a myriad of issues faced by children with mental illness and the pediatricians who care for them.
Mental health: The secret sauce to healthcare reformMental health advocate Patrick J. Kennedy talks to Managed Healthcare Executive about reform, mental health equity, and how payers can help integrate care in mental health.
Injectable schizophrenia drug gets FDA green lightFDA has approved aripiprazole lauroxil (Aristada, Alkermes) extended-release injectable suspension for the treatment of adults with schizophrenia.
A new approach to care management for patients with comorbiditiesApproximately half of all adults in the U.S. have one or more chronic health conditions, and 75% of health care costs are due to chronic illnesses. When psychosocial issues like depression, low income, or lack of social support are present, the impact on costs is even greater.
Nurses are on the front line in treating, recognizing mental illnessAlthough every nurse receives basic education for caring for psychiatric patients, the complexity of patient care continues to be a challenge.
Does maternal inflammation increase the chance of schizophrenia?Maternal inflammation during pregnancy may be linked to a risk of schizophrenia in the woman’s offspring, according to a new study in The American Journal of Psychiatry based on analysis of data from a large Finnish cohort.